{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:32:14Z","timestamp":1761823934601,"version":"3.44.0"},"reference-count":55,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH\/NIAID","award":["AI105170","AI119366","AI093772"],"award-info":[{"award-number":["AI105170","AI119366","AI093772"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.virol.2017.08.022","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T04:31:41Z","timestamp":1504067501000},"page":"142-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus"],"prefix":"10.1016","volume":"511","author":[{"given":"Hye Suk","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Tae","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki-Hye","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eun-Ju","family":"Ko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youri","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young-Man","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang-Moo","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2017.08.022_bib1","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/rr39","article-title":"Th2 cytokines and asthma: an introduction","volume":"2","author":"Barnes","year":"2001","journal-title":"Respir. Res."},{"key":"10.1016\/j.virol.2017.08.022_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/S0264-410X(00)00213-9","article-title":"Both immunisation with a formalin-inactivated respiratory syncytial virus (RSV) vaccine and a mock antigen vaccine induce severe lung pathology and a Th2 cytokine profile in RSV-challenged mice","volume":"19","author":"Boelen","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/jmv.2180","article-title":"Effect of lack of Interleukin-4, Interleukin-12, Interleukin-18, or the Interferon-gamma receptor on virus replication, cytokine response, and lung pathology during respiratory syncytial virus infection in mice","volume":"66","author":"Boelen","year":"2002","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/jir.2009.0025","article-title":"Activation of interferon response through toll-like receptor 3 impacts viral pathogenesis and pulmonary toll-like receptor expression during respiratory syncytial virus and influenza infections in the cotton rat Sigmodon hispidus model","volume":"30","author":"Boukhvalova","year":"2010","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.virol.2017.08.022_bib5","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.4049\/jimmunol.180.4.2376","article-title":"IL-13 is required for eosinophil entry into the lung during respiratory syncytial virus vaccine-enhanced disease","volume":"180","author":"Castilow","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.08.022_bib6","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1128\/JVI.01949-07","article-title":"Differential role of gamma interferon in inhibiting pulmonary eosinophilia and exacerbating systemic disease in fusion protein-immunized mice undergoing challenge infection with respiratory syncytial virus","volume":"82","author":"Castilow","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s12026-007-0071-6","article-title":"Understanding respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"39","author":"Castilow","year":"2007","journal-title":"Immunol. Res."},{"key":"10.1016\/j.virol.2017.08.022_bib8","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-4933-9-21","article-title":"An adjuvanted respiratory syncytial virus fusion protein induces protection in aged BALB\/c mice","volume":"9","author":"Cherukuri","year":"2012","journal-title":"Immun. Ageing: I & A"},{"key":"10.1016\/j.virol.2017.08.022_bib9","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1128\/jvi.65.3.1634-1637.1991","article-title":"Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived","volume":"65","author":"Connors","year":"1991","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib10","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/0264-410X(92)90397-3","article-title":"Cotton rats previously immunized with a chimeric RSV FG glycoprotein develop enhanced pulmonary pathology when infected with RSV, a phenomenon not encountered following immunization with vaccinia--RSV recombinants or RSV","volume":"10","author":"Connors","year":"1992","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib11","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1128\/jvi.68.8.5321-5325.1994","article-title":"Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10","volume":"68","author":"Connors","year":"1994","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib12","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/jvi.66.2.1277-1281.1992","article-title":"Resistance to respiratory syncytial virus (RSV) challenge induced by infection with a vaccinia virus recombinant expressing the RSV M2 protein (Vac-M2) is mediated by CD8+ T cells, while that induced by Vac-F or Vac-G recombinants is mediated by antibodies","volume":"66","author":"Connors","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib13","doi-asserted-by":"crossref","first-page":"7444","DOI":"10.1128\/jvi.66.12.7444-7451.1992","article-title":"Pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB\/c mice is abrogated by depletion of CD4+ T cells","volume":"66","author":"Connors","year":"1992","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib14","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.4049\/jimmunol.158.5.2278","article-title":"Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization","volume":"158","author":"Feltquate","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.08.022_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1086\/314947","article-title":"Vaccination with pertussis toxin alters the antibody response to simultaneous respiratory syncytial virus challenge","volume":"180","author":"Fischer","year":"1999","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.08.022_bib16","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1056\/NEJMc1313186","article-title":"A recombinant viruslike particle influenza A (H7N9) vaccine","volume":"369","author":"Fries","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2017.08.022_bib17","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0264-410X(98)80123-0","article-title":"A bovine model of vaccine enhanced respiratory syncytial virus pathophysiology","volume":"16","author":"Gershwin","year":"1998","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1203\/00006450-199308000-00013","article-title":"Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum","volume":"34","author":"Graham","year":"1993","journal-title":"Pediatr. Res."},{"key":"10.1016\/j.virol.2017.08.022_bib19","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0264-410X(94)90204-6","article-title":"The pulmonary immune response of Balb\/c mice vaccinated with the fusion protein of respiratory syncytial virus","volume":"12","author":"Hancock","year":"1994","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib20","doi-asserted-by":"crossref","first-page":"4874","DOI":"10.1016\/S0264-410X(01)00228-6","article-title":"CpG containing oligodeoxynucleotides are potent adjuvants for parenteral vaccination with the fusion (F) protein of respiratory syncytial virus (RSV)","volume":"19","author":"Hancock","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib21","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1002\/eji.1830271233","article-title":"CD8+ T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection","volume":"27","author":"Hussell","year":"1997","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.virol.2017.08.022_bib22","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.antiviral.2014.07.016","article-title":"Co-immunization with virus-like particle and DNA vaccines induces protection against respiratory syncytial virus infection and bronchiolitis","volume":"110C","author":"Hwang","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2017.08.022_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.virol.2016.04.014","article-title":"Combined virus-like particle and fusion protein-encoding DNA vaccination of cotton rats induces protection against respiratory syncytial virus without causing vaccine-enhanced disease","volume":"494","author":"Hwang","year":"2016","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.08.022_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1099\/0022-1317-83-2-429","article-title":"Virus-specific CTL responses induced by an H-2K(d)-restricted, motif-negative 15-mer peptide from the fusion protein of respiratory syncytial virus","volume":"83","author":"Jiang","year":"2002","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib25","doi-asserted-by":"crossref","first-page":"6024","DOI":"10.1128\/JVI.78.11.6024-6032.2004","article-title":"Respiratory syncytial virus (RSV) G glycoprotein is not necessary for vaccine-enhanced disease induced by immunization with formalin-inactivated RSV","volume":"78","author":"Johnson","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib26","doi-asserted-by":"crossref","first-page":"e36812","DOI":"10.1371\/journal.pone.0036812","article-title":"Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in mice","volume":"7","author":"Kamphuis","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2017.08.022_bib27","doi-asserted-by":"crossref","first-page":"10945","DOI":"10.1128\/JVI.05406-11","article-title":"H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans","volume":"85","author":"Khurana","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib28","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2017.08.022_bib29","doi-asserted-by":"crossref","first-page":"11692","DOI":"10.1128\/JVI.02018-15","article-title":"Virus-like particle vaccine containing the F protein of respiratory syncytial virus confers protection without pulmonary disease by modulating specific subsets of dendritic cells and effector T cells","volume":"89","author":"Kim","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/mt.2014.33","article-title":"Supplementation of Influenza split vaccines with conserved M2 ectodomains overcomes strain specificity and provides long-term cross protection","author":"Kim","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2017.08.022_bib31","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.1600173","article-title":"Roles of aluminum hydroxide and monophosphoryl lipid A adjuvants in overcoming CD4+ T cell deficiency to induce isotype-switched IgG antibody responses and protection by T-dependent influenza vaccine","author":"Ko","year":"2017","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.08.022_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2014.01.008","article-title":"Maternal antibodies by passive immunization with formalin inactivated respiratory syncytial virus confer protection without vaccine-enhanced disease","volume":"104","author":"Kwon","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2017.08.022_bib33","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.antiviral.2014.09.005","article-title":"Additive protection induced by mixed virus-like particles presenting respiratory syncytial virus fusion or attachment glycoproteins","volume":"111C","author":"Lee","year":"2014","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2017.08.022_bib34","doi-asserted-by":"crossref","first-page":"4578","DOI":"10.1016\/j.vaccine.2014.06.040","article-title":"AS04-adjuvanted virus-like particles containing multiple M2 extracellular domains of influenza virus confer improved protection","volume":"32","author":"Lee","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib35","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.virol.2015.07.001","article-title":"Innate and adaptive cellular phenotypes contributing to pulmonary disease in mice after respiratory syncytial virus immunization and infection","volume":"485","author":"Lee","year":"2015","journal-title":"Virology"},{"key":"10.1016\/j.virol.2017.08.022_bib36","article-title":"Cellular immune correlates preventing disease against respiratory syncytial virus by virus-like particle vaccine","author":"Lee","year":"2017","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.virol.2017.08.022_bib37","doi-asserted-by":"crossref","first-page":"7826","DOI":"10.1016\/j.vaccine.2011.07.099","article-title":"Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine in a blinded, randomized, placebo-controlled trial of adults in Mexico","volume":"29","author":"Lopez-Macias","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib38","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1128\/JVI.01861-10","article-title":"Assembly and immunological properties of Newcastle disease virus-like particles containing the respiratory syncytial virus F and G proteins","volume":"85","author":"McGinnes","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/0192623308329342","article-title":"Comparison of histochemical methods for murine eosinophil detection in an RSV vaccine-enhanced inflammation model","volume":"37","author":"Meyerholz","year":"2009","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.virol.2017.08.022_bib40","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/JVI.01709-09","article-title":"Newcastle disease virus-like particles containing respiratory syncytial virus G protein induced protection in BALB\/c mice, with no evidence of immunopathology","volume":"84","author":"Murawski","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0168-1702(88)90063-9","article-title":"Current approaches to the development of vaccines effective against parainfluenza and respiratory syncytial viruses","volume":"11","author":"Murphy","year":"1988","journal-title":"Virus Res."},{"key":"10.1016\/j.virol.2017.08.022_bib42","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/0264-410X(90)90253-I","article-title":"Enhanced pulmonary histopathology is observed in cotton rats immunized with formalin-inactivated respiratory syncytial virus (RSV) or purified F glycoprotein and challenged with RSV 3-6 months after immunization","volume":"8","author":"Murphy","year":"1990","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2017.08.022_bib43","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.4049\/jimmunol.179.8.5415","article-title":"CD8 T cells inhibit respiratory syncytial virus (RSV) vaccine-enhanced disease","volume":"179","author":"Olson","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.virol.2017.08.022_bib44","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1586\/14760584.7.8.1239","article-title":"Pulmonary immunity and immunopathology: lessons from respiratory syncytial virus","volume":"7","author":"Olson","year":"2008","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.virol.2017.08.022_bib45","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/intimm\/4.4.493","article-title":"Pulmonary eosinophilic response to respiratory syncytial virus infection in mice sensitized to the major surface glycoprotein G","volume":"4","author":"Openshaw","year":"1992","journal-title":"Int. Immunol."},{"key":"10.1016\/j.virol.2017.08.022_bib46","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1084\/jem.20020781","article-title":"A role for immune complexes in enhanced respiratory syncytial virus disease","volume":"196","author":"Polack","year":"2002","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.virol.2017.08.022_bib47","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1099\/0022-1317-82-12-2881","article-title":"Vaccine-enhanced respiratory syncytial virus disease in cotton rats following immunization with Lot 100 or a newly prepared reference vaccine","volume":"82","author":"Prince","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib48","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1128\/jvi.57.3.721-728.1986","article-title":"Enhancement of respiratory syncytial virus pulmonary pathology in cotton rats by prior intramuscular inoculation of formalin-inactiva ted virus","volume":"57","author":"Prince","year":"1986","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib49","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/infdis\/jir474","article-title":"Viruslike particle vaccine induces protection against respiratory syncytial virus infection in mice","volume":"204","author":"Quan","year":"2011","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.08.022_bib50","first-page":"91","article-title":"Immunization with low doses of recombinant postfusion or prefusion respiratory syncytial virus F primes for vaccine-enhanced disease in the cotton rat model independently of the presence of a Th1-Biasing (GLA-SE) or Th2-Biasing (Alum) adjuvant","author":"Schneider-Ohrum","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib51","doi-asserted-by":"crossref","first-page":"e50852","DOI":"10.1371\/journal.pone.0050852","article-title":"Respiratory syncytial virus fusion glycoprotein expressed in insect cells form protein nanoparticles that induce protective immunity in cotton rats","volume":"7","author":"Smith","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2017.08.022_bib52","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1128\/jvi.71.1.678-685.1997","article-title":"Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection","volume":"71","author":"Srikiatkhachorn","year":"1997","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2017.08.022_bib53","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S1074-7613(01)00209-6","article-title":"Immunopathology in RSV infection is mediated by a discrete oligoclonal subset of antigen-specific CD4(+) T cells","volume":"15","author":"Varga","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.virol.2017.08.022_bib54","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/infdis\/170.2.345","article-title":"Humoral, mucosal, and cellular immune response to topical immunization with a subunit respiratory syncytial virus vaccine","volume":"170","author":"Walsh","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.virol.2017.08.022_bib55","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1128\/jvi.70.5.2852-2860.1996","article-title":"Respiratory synctial virus infection in BALB\/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern","volume":"70","author":"Waris","year":"1996","journal-title":"J. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217302842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682217302842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:42:32Z","timestamp":1758588152000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682217302842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":55,"alternative-id":["S0042682217302842"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2017.08.022","relation":{},"ISSN":["0042-6822"],"issn-type":[{"type":"print","value":"0042-6822"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Virus-like particle vaccine primes immune responses preventing inactivated-virus vaccine-enhanced disease against respiratory syncytial virus","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2017.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}